HEADER TRANSFERASE/TRANSFERASE INHIBITOR 25-SEP-18 6IG8 TITLE CRYSTAL STRUCTURE OF CSF-1R KINASE DOMAIN WITH A SMALL MOLECULAR TITLE 2 INHIBITOR, JTE-952 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CSF-1 RECEPTOR,M-CSF-R,PROTO-ONCOGENE C-FMS; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSF1R, FMS; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PPSC8 KEYWDS CSF-1-R, FMS PROTO-ONCOGENE, C-FMS, CD115 ANTIGEN, KINASE, ATP- KEYWDS 2 BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.DOI,T.ADACHI REVDAT 2 22-NOV-23 6IG8 1 LINK REVDAT 1 07-AUG-19 6IG8 0 JRNL AUTH K.IKEGASHIRA,T.IKENOGAMI,T.YAMASAKI,Y.HASE,T.YAMAGUCHI, JRNL AUTH 2 K.INAGAKI,S.DOI,T.ADACHI,Y.KOGA,H.HASHIMOTO JRNL TITL DISCOVERY OF A NOVEL AZETIDINE SCAFFOLD FOR COLONY JRNL TITL 2 STIMULATING FACTOR-1 RECEPTOR (CSF-1R) TYPE II INHIBITORS BY JRNL TITL 3 THE USE OF DOCKING MODELS. JRNL REF BIOORG.MED.CHEM.LETT. V. 29 115 2019 JRNL REFN ESSN 1464-3405 JRNL PMID 30442420 JRNL DOI 10.1016/J.BMCL.2018.10.051 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0232 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 33140 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.158 REMARK 3 R VALUE (WORKING SET) : 0.156 REMARK 3 FREE R VALUE : 0.192 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1751 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2417 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.73 REMARK 3 BIN R VALUE (WORKING SET) : 0.2070 REMARK 3 BIN FREE R VALUE SET COUNT : 124 REMARK 3 BIN FREE R VALUE : 0.2430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2368 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 370 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.48000 REMARK 3 B22 (A**2) : 0.48000 REMARK 3 B33 (A**2) : -0.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.105 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.104 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.069 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.225 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2599 ; 0.015 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2424 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3538 ; 1.704 ; 1.652 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5641 ; 1.588 ; 1.591 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 326 ; 6.607 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 124 ;33.785 ;22.984 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 442 ;12.498 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;20.040 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 323 ; 0.111 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2938 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 549 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6IG8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1300009130. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97872 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35007 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 59.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 8.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07900 REMARK 200 FOR THE DATA SET : 18.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.40 REMARK 200 R MERGE FOR SHELL (I) : 0.52400 REMARK 200 R SYM FOR SHELL (I) : 0.52400 REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 3LCO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 11 MG/ML PROTEIN, 22.5-35% PEG 4000, REMARK 280 0.1M TRIS-HCL PH 8.5, 0.2M MGCL2, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 92.65500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 31.26000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 31.26000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 138.98250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 31.26000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 31.26000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 46.32750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 31.26000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 31.26000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 138.98250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 31.26000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 31.26000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 46.32750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 92.65500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1427 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1470 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 555 REMARK 465 TYR A 556 REMARK 465 GLU A 557 REMARK 465 GLY A 558 REMARK 465 ASN A 559 REMARK 465 SER A 560 REMARK 465 TYR A 561 REMARK 465 ALA A 688 REMARK 465 PRO A 689 REMARK 465 GLY A 690 REMARK 465 GLN A 691 REMARK 465 ASP A 692 REMARK 465 PRO A 693 REMARK 465 GLU A 694 REMARK 465 GLY A 695 REMARK 465 LEU A 742 REMARK 465 ASP A 743 REMARK 465 LYS A 744 REMARK 465 GLU A 745 REMARK 465 ASP A 746 REMARK 465 ASP A 917 REMARK 465 ARG A 918 REMARK 465 ARG A 919 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 777 -3.25 74.97 REMARK 500 ASP A 778 48.86 -142.55 REMARK 500 THR A 787 -168.53 -109.08 REMARK 500 GLN A 915 69.72 -101.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 SER A 638 -11.11 REMARK 500 SER A 638 -12.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1470 DISTANCE = 6.76 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1001 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 608 OD1 REMARK 620 2 GLU A 912 OE2 62.8 REMARK 620 3 HOH A1142 O 82.6 101.4 REMARK 620 4 HOH A1194 O 86.6 30.5 86.5 REMARK 620 5 HOH A1263 O 86.8 69.5 168.5 88.3 REMARK 620 6 HOH A1273 O 176.3 117.8 93.7 92.8 96.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1002 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A1140 O REMARK 620 2 HOH A1146 O 84.3 REMARK 620 3 HOH A1329 O 88.4 105.0 REMARK 620 4 HOH A1374 O 86.9 84.5 169.0 REMARK 620 5 HOH A1402 O 94.1 177.0 77.5 92.9 REMARK 620 6 HOH A1421 O 173.0 89.3 96.1 89.7 92.1 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue A7O A 1004 DBREF 6IG8 A 550 695 UNP P07333 CSF1R_HUMAN 550 695 DBREF 6IG8 A 742 919 UNP P07333 CSF1R_HUMAN 742 919 SEQADV 6IG8 ALA A 688 UNP P07333 SER 688 ENGINEERED MUTATION SEQRES 1 A 324 TRP LYS ILE ILE GLU SER TYR GLU GLY ASN SER TYR THR SEQRES 2 A 324 PHE ILE ASP PRO THR GLN LEU PRO TYR ASN GLU LYS TRP SEQRES 3 A 324 GLU PHE PRO ARG ASN ASN LEU GLN PHE GLY LYS THR LEU SEQRES 4 A 324 GLY ALA GLY ALA PHE GLY LYS VAL VAL GLU ALA THR ALA SEQRES 5 A 324 PHE GLY LEU GLY LYS GLU ASP ALA VAL LEU LYS VAL ALA SEQRES 6 A 324 VAL LYS MET LEU LYS SER THR ALA HIS ALA ASP GLU LYS SEQRES 7 A 324 GLU ALA LEU MET SER GLU LEU LYS ILE MET SER HIS LEU SEQRES 8 A 324 GLY GLN HIS GLU ASN ILE VAL ASN LEU LEU GLY ALA CYS SEQRES 9 A 324 THR HIS GLY GLY PRO VAL LEU VAL ILE THR GLU TYR CYS SEQRES 10 A 324 CYS TYR GLY ASP LEU LEU ASN PHE LEU ARG ARG LYS ALA SEQRES 11 A 324 GLU ALA MET LEU GLY PRO SER LEU ALA PRO GLY GLN ASP SEQRES 12 A 324 PRO GLU GLY LEU ASP LYS GLU ASP GLY ARG PRO LEU GLU SEQRES 13 A 324 LEU ARG ASP LEU LEU HIS PHE SER SER GLN VAL ALA GLN SEQRES 14 A 324 GLY MET ALA PHE LEU ALA SER LYS ASN CYS ILE HIS ARG SEQRES 15 A 324 ASP VAL ALA ALA ARG ASN VAL LEU LEU THR ASN GLY HIS SEQRES 16 A 324 VAL ALA LYS ILE GLY ASP PHE GLY LEU ALA ARG ASP ILE SEQRES 17 A 324 MET ASN ASP SER ASN TYR ILE VAL LYS GLY ASN ALA ARG SEQRES 18 A 324 LEU PRO VAL LYS TRP MET ALA PRO GLU SER ILE PHE ASP SEQRES 19 A 324 CYS VAL TYR THR VAL GLN SER ASP VAL TRP SER TYR GLY SEQRES 20 A 324 ILE LEU LEU TRP GLU ILE PHE SER LEU GLY LEU ASN PRO SEQRES 21 A 324 TYR PRO GLY ILE LEU VAL ASN SER LYS PHE TYR LYS LEU SEQRES 22 A 324 VAL LYS ASP GLY TYR GLN MET ALA GLN PRO ALA PHE ALA SEQRES 23 A 324 PRO LYS ASN ILE TYR SER ILE MET GLN ALA CYS TRP ALA SEQRES 24 A 324 LEU GLU PRO THR HIS ARG PRO THR PHE GLN GLN ILE CYS SEQRES 25 A 324 SER PHE LEU GLN GLU GLN ALA GLN GLU ASP ARG ARG HET MG A1001 1 HET MG A1002 1 HET GOL A1003 6 HET A7O A1004 38 HETNAM MG MAGNESIUM ION HETNAM GOL GLYCEROL HETNAM A7O (3-{4-[(4-CYCLOPROPYLPHENYL)METHOXY]-3- HETNAM 2 A7O METHOXYPHENYL}AZETIDIN-1-YL)(4-{[(2S)-2,3- HETNAM 3 A7O DIHYDROXYPROPOXY]METHYL}PYRIDIN-2-YL)METHANONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 MG 2(MG 2+) FORMUL 4 GOL C3 H8 O3 FORMUL 5 A7O C30 H34 N2 O6 FORMUL 6 HOH *370(H2 O) HELIX 1 AA1 ASP A 565 LEU A 569 5 5 HELIX 2 AA2 ASN A 572 GLU A 576 5 5 HELIX 3 AA3 PRO A 578 ASN A 580 5 3 HELIX 4 AA4 HIS A 623 GLY A 641 1 19 HELIX 5 AA5 LEU A 671 GLY A 684 1 14 HELIX 6 AA6 GLU A 751 LYS A 772 1 22 HELIX 7 AA7 ALA A 780 ARG A 782 5 3 HELIX 8 AA8 ASN A 788 HIS A 790 5 3 HELIX 9 AA9 PHE A 797 ARG A 801 5 5 HELIX 10 AB1 PRO A 818 MET A 822 5 5 HELIX 11 AB2 ALA A 823 CYS A 830 1 8 HELIX 12 AB3 THR A 833 SER A 850 1 18 HELIX 13 AB4 ASN A 862 ASP A 871 1 10 HELIX 14 AB5 PRO A 882 TRP A 893 1 12 HELIX 15 AB6 GLU A 896 ARG A 900 5 5 HELIX 16 AB7 THR A 902 GLN A 915 1 14 SHEET 1 AA1 2 LYS A 551 ILE A 552 0 SHEET 2 AA1 2 CYS A 774 ILE A 775 -1 O ILE A 775 N LYS A 551 SHEET 1 AA2 5 LEU A 582 ALA A 590 0 SHEET 2 AA2 5 GLY A 594 LEU A 604 -1 O VAL A 596 N LEU A 588 SHEET 3 AA2 5 ALA A 609 LEU A 618 -1 O VAL A 613 N ALA A 599 SHEET 4 AA2 5 LEU A 660 GLU A 664 -1 O THR A 663 N ALA A 614 SHEET 5 AA2 5 LEU A 649 CYS A 653 -1 N LEU A 650 O ILE A 662 SHEET 1 AA3 3 GLY A 669 ASP A 670 0 SHEET 2 AA3 3 VAL A 784 THR A 787 -1 O LEU A 786 N GLY A 669 SHEET 3 AA3 3 VAL A 791 ILE A 794 -1 O LYS A 793 N LEU A 785 SHEET 1 AA4 2 ILE A 810 LYS A 812 0 SHEET 2 AA4 2 ALA A 815 LEU A 817 -1 O LEU A 817 N ILE A 810 LINK OD1 ASP A 608 MG MG A1001 1555 1555 2.02 LINK OE2 GLU A 912 MG MG A1001 1555 4455 2.10 LINK MG MG A1001 O HOH A1142 1555 3554 2.15 LINK MG MG A1001 O HOH A1194 1555 1555 2.07 LINK MG MG A1001 O HOH A1263 1555 1555 2.12 LINK MG MG A1001 O HOH A1273 1555 3554 2.14 LINK MG MG A1002 O HOH A1140 1555 3554 2.36 LINK MG MG A1002 O HOH A1146 1555 1555 2.18 LINK MG MG A1002 O HOH A1329 1555 1555 1.82 LINK MG MG A1002 O HOH A1374 1555 3554 2.15 LINK MG MG A1002 O HOH A1402 1555 3554 2.37 LINK MG MG A1002 O HOH A1421 1555 1555 2.18 SITE 1 AC1 6 ASP A 608 GLU A 912 HOH A1142 HOH A1194 SITE 2 AC1 6 HOH A1263 HOH A1273 SITE 1 AC2 6 HOH A1140 HOH A1146 HOH A1329 HOH A1374 SITE 2 AC2 6 HOH A1402 HOH A1421 SITE 1 AC3 7 LYS A 574 GLY A 605 HIS A 623 ASP A 625 SITE 2 AC3 7 HOH A1111 HOH A1112 HOH A1158 SITE 1 AC4 18 TRP A 550 ALA A 614 MET A 637 THR A 663 SITE 2 AC4 18 GLU A 664 TYR A 665 CYS A 666 CYS A 667 SITE 3 AC4 18 GLY A 669 CYS A 774 HIS A 776 ASN A 783 SITE 4 AC4 18 LEU A 785 GLY A 795 ASP A 796 PHE A 797 SITE 5 AC4 18 HOH A1184 HOH A1256 CRYST1 62.520 62.520 185.310 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015995 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015995 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005396 0.00000